Histogen Inc logo

HSTO - Histogen Inc News Story

$0.811 0.0  2.5%

Last Trade - 22/09/21

Sector
Healthcare
Size
Micro Cap
Market Cap £24.2m
Enterprise Value £6.52m
Revenue £1.03m
Position in Universe 6243rd / 7153

Histogen to Report Second Quarter 2021 Financial Results on August 11, 2021

Wed 28th July, 2021 9:05pm
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210728:nGNX3m09nF&default-theme=true


SAN DIEGO, July 28, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a
clinical-stage therapeutics company focused on developing potential
first-in-class restorative therapeutics that ignite the body’s natural
process to repair and maintain healthy biological function, today announced
that Histogen’s financial results for the second quarter will be released
after the close of market on Wednesday, August 11, 2021.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing
potential first-in-class restorative therapeutics that ignite the body’s
natural process to repair and maintain healthy biological function.
Histogen’s innovative technology platform utilizes cell conditioned media
and extracellular matrix materials produced by hypoxia-induced multipotent
cells. Histogen’s proprietary, reproducible manufacturing process provides
targeted solutions across a broad range of therapeutic indications including
joint cartilage regeneration, spinal disk repair, hair growth and dermal
rejuvenation. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO 
Histogen Inc. 
ir@histogen.com


(https://www.globenewswire.com/NewsRoom/AttachmentNg/5a42687c-9cb2-4dbf-960e-60f9776dd598)



GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.